Pages that link to "Q34431411"
Jump to navigation
Jump to search
The following pages link to Bone marrow failure and the telomeropathies (Q34431411):
Displaying 50 items.
- Therapeutic Targeting of Telomerase (Q26741736) (← links)
- Telomeres and telomerase as therapeutic targets to prevent and treat age-related diseases (Q26747735) (← links)
- Telomerase Activation in Hematological Malignancies (Q28068238) (← links)
- Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering (Q28083303) (← links)
- Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer (Q28384025) (← links)
- Danazol Treatment for Telomere Diseases (Q29307230) (← links)
- Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on La (Q30234389) (← links)
- Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium Internati (Q30238875) (← links)
- Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction. (Q30240298) (← links)
- Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia. (Q30249748) (← links)
- Ribosomopathies and the paradox of cellular hypo- to hyperproliferation. (Q34457472) (← links)
- Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. (Q34555435) (← links)
- Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly (Q34556382) (← links)
- Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice (Q35680392) (← links)
- Impaired telomere maintenance in Alazami syndrome patients with LARP7 deficiency (Q36170330) (← links)
- A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition (Q36411101) (← links)
- Disrupted lymphocyte homeostasis in hepatitis-associated acquired aplastic anemia is associated with short telomeres. (Q36494312) (← links)
- A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation (Q36782745) (← links)
- Anemia of Central Origin (Q36784115) (← links)
- The shelterin complex and hematopoiesis. (Q36867317) (← links)
- Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L. (Q37005060) (← links)
- Mutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects. (Q37178997) (← links)
- Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis (Q37304109) (← links)
- The dynamics of adult haematopoiesis in the bone and bone marrow environment (Q38411878) (← links)
- The wide-ranging clinical implications of the short telomere syndromes (Q38561757) (← links)
- Nontransplant therapy for bone marrow failure (Q38787787) (← links)
- Mammalian telomeres and their partnership with lamins. (Q38818114) (← links)
- Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes. (Q38843000) (← links)
- Sixty as the new forty: considerations on older related stem cell donors (Q38921661) (← links)
- Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists. (Q39000607) (← links)
- Aplastic anemia and clonal evolution: germ line and somatic genetics (Q39027706) (← links)
- Progress in Human and Tetrahymena Telomerase Structure Determination (Q39182224) (← links)
- Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review (Q39269167) (← links)
- Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia (Q39446192) (← links)
- Structural biology of telomerase and its interaction at telomeres (Q39450767) (← links)
- Pushing the limits: defeating leukemia stem cells by depleting telomerase (Q39551272) (← links)
- Telomere length is an independent prognostic marker in MDS but not in de novo AML. (Q40208892) (← links)
- Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms (Q40331582) (← links)
- DNA methylation in PRDM8 is indicative for dyskeratosis congenita (Q42142244) (← links)
- A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding (Q42381247) (← links)
- Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening (Q42660517) (← links)
- Severe combined immunodeficiencies and related disorders (Q45886049) (← links)
- Biological and clinical implications of telomere dysfunction in myeloid malignancies (Q46980175) (← links)
- Insights from human genetic studies of lung and organ fibrosis (Q47239342) (← links)
- Retinal findings and a novel TINF2 mutation in Revesz syndrome: Clinical and molecular correlations with pediatric retinal vasculopathies (Q47341406) (← links)
- Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts. (Q47774343) (← links)
- Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes. (Q48335168) (← links)
- Telomerase enzyme deficiency promotes metabolic dysfunction in murine hepatocytes upon dietary stress. (Q48351718) (← links)
- Aging, hematopoiesis, and the myelodysplastic syndromes. (Q49989285) (← links)
- Comparison of telomere length measurement methods. (Q52715473) (← links)